239 related articles for article (PubMed ID: 30071272)
1. Carbamylation promotes amyloidogenesis and induces structural changes in Tau-core hexapeptide fibrils.
Guru KrishnaKumar V; Baweja L; Ralhan K; Gupta S
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2590-2604. PubMed ID: 30071272
[TBL] [Abstract][Full Text] [Related]
2. Charge neutralization of lysine via carbamylation reveals hidden aggregation hot-spots in tau protein flanking regions.
Gadhavi J; Shah S; Sinha T; Jain A; Gupta S
FEBS J; 2022 May; 289(9):2562-2577. PubMed ID: 34796642
[TBL] [Abstract][Full Text] [Related]
3. Primary Fibril Nucleation of Aggregation Prone Tau Fragments PHF6 and PHF6.
Smit FX; Luiken JA; Bolhuis PG
J Phys Chem B; 2017 Apr; 121(15):3250-3261. PubMed ID: 27776213
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone-Dopamine hybrid.
Paul A; Viswanathan GK; Huber A; Arad E; Engel H; Jelinek R; Gazit E; Segal D
FEBS J; 2021 Jul; 288(14):4267-4290. PubMed ID: 33523571
[TBL] [Abstract][Full Text] [Related]
5. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils.
Haj E; Losev Y; Guru KrishnaKumar V; Pichinuk E; Engel H; Raveh A; Gazit E; Segal D
Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1565-1575. PubMed ID: 29634991
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation regulates fibrillation of an aggregation core peptide in the second repeat of microtubule-binding domain of human tau.
Inoue M; Kaida S; Nakano S; Annoni C; Nakata E; Konno T; Morii T
Bioorg Med Chem; 2014 Nov; 22(22):6471-80. PubMed ID: 25440728
[TBL] [Abstract][Full Text] [Related]
7. Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils.
Inoue M; Konno T; Tainaka K; Nakata E; Yoshida HO; Morii T
Biochemistry; 2012 Feb; 51(7):1396-406. PubMed ID: 22304362
[TBL] [Abstract][Full Text] [Related]
8. Secondary nucleating sequences affect kinetics and thermodynamics of tau aggregation.
Moore CL; Huang MH; Robbennolt SA; Voss KR; Combs B; Gamblin TC; Goux WJ
Biochemistry; 2011 Dec; 50(50):10876-86. PubMed ID: 22085312
[TBL] [Abstract][Full Text] [Related]
9. Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity.
Arya S; Ganguly P; Arsiccio A; Claud SL; Trapp B; Schonfeld GE; Liu X; Lazar Cantrell K; Shea JE; Bowers MT
J Phys Chem B; 2020 Oct; 124(40):8772-8783. PubMed ID: 32816481
[TBL] [Abstract][Full Text] [Related]
10. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.
Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; Gosselet F; Gazit E; Segal D
Cell Mol Life Sci; 2020 Jul; 77(14):2795-2813. PubMed ID: 31562564
[TBL] [Abstract][Full Text] [Related]
11. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation.
Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X
ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.
KrishnaKumar VG; Paul A; Gazit E; Segal D
Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706
[TBL] [Abstract][Full Text] [Related]
13. Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6.
Fanni AM; Vander Zanden CM; Majewska PV; Majewski J; Chi EY
J Biol Chem; 2019 Oct; 294(42):15304-15317. PubMed ID: 31439664
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations.
Li X; Chen Y; Yang Z; Zhang S; Wei G; Zhang L
Int J Biol Macromol; 2024 Jan; 254(Pt 2):127841. PubMed ID: 37924907
[TBL] [Abstract][Full Text] [Related]
15. Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer.
Berhanu WM; Masunov AE
J Biomol Struct Dyn; 2015; 33(7):1399-411. PubMed ID: 25093402
[TBL] [Abstract][Full Text] [Related]
16. Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease.
Dammers C; Yolcu D; Kukuk L; Willbold D; Pickhardt M; Mandelkow E; Horn AH; Sticht H; Malhis MN; Will N; Schuster J; Funke SA
PLoS One; 2016; 11(12):e0167432. PubMed ID: 28006031
[TBL] [Abstract][Full Text] [Related]
17. Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling.
Shah SJA; Zhang Q; Guo J; Liu H; Liu H; Villà-Freixa J
ACS Chem Neurosci; 2023 Nov; 14(21):3959-3971. PubMed ID: 37830541
[TBL] [Abstract][Full Text] [Related]
18. Selective Inhibition of Aggregation and Toxicity of a Tau-Derived Peptide using Its Glycosylated Analogues.
Frenkel-Pinter M; Richman M; Belostozky A; Abu-Mokh A; Gazit E; Rahimipour S; Segal D
Chemistry; 2016 Apr; 22(17):5945-52. PubMed ID: 26891276
[TBL] [Abstract][Full Text] [Related]
19. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
[TBL] [Abstract][Full Text] [Related]
20. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
Kreutzer AG; Nowick JS
Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
